Validity and Reliability of Sensorimotor Processing Paradigm
NCT ID: NCT06382558
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2024-04-10
2025-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potential Effects of Novel Sensorimotor Upper Limb Rehabilitation Paradigm
NCT06870682
Robotic Assessment of Upper Limb Passive and Active Sensory Processing in Healthy Adults
NCT04723212
Towards Understanding Upper Limb Rehabilitation After Stroke
NCT04721561
Robot-based Therapy for Upper Limb Sensorimotor Impairments After Stroke
NCT05007002
Perception of Verticality After Stroke
NCT03019432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Within a previous study of our research team, a novel robotic assessment of sensory processing was developed, using the Kinarm End-Point Lab (BKIN Technologies Ltd., Canada). That study was set up to initially validate this novel robotic assessment and to collect pilot data to form the basis for future research. 20 chronic stroke patients and 80 age-matched controls underwent extensive clinical and robotic assessment of upper limb motor and somatosensory function. For the cross-sectional study, the investigators aim to build further on this previous research. By recruiting 60 additional chronic stroke patients and combining both data of the previous study and this study, the investigators aim to examine the validity and reliability of this novel assessment in a bigger and more heterogeneous group of chronic stroke participants. The investigators hypothesize that stoke patients have a worse performance on this novel robotic assessment compared to healthy controls, that the novel assessment correlates more to standard sensory assessments compared to standard motor assessments, that the novel assessment can differentiate between motor subgroups of chronic stroke patients, and that the novel assessment shows good test-retest reliability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic stroke patients
Patients who experienced a first unilateral stroke at least 6 months ago
No interventions assigned to this group
Healthy controls
Healthy subjects with no history of any neurological condition and who are in the same age group as the chronic stroke patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. First-ever unilateral, supra-tentorial stroke (as defined by WHO)
3. At least 18 years old
4. Being in the chronic phase after stroke (i.e. being at least 6 months after stroke)
5. Motor impairment in the upper limb, defined as Fugl-Meyer score \>22 out of 66 to demonstrate moderate to full upper limb motor function (patients scoring \<23 out of 66 will not be able to comply with the KINARM protocol)
Exclusion Criteria
2. Severe communication or cognitive deficits that interfere with the protocol
3. Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the CIP.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Geert Verheyden
Prof. Dr. Geert Verheyden
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert Verheyden
Role: PRINCIPAL_INVESTIGATOR
KU Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KU Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C2M/23/060
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
s68470
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.